The cause of urinary symptoms among Human T Lymphotropic Virus Type I (HLTV-I) infected patients: a cross sectional study by Paulo N Rocha et al.
BioMed CentralBMC Infectious Diseases
ssOpen AcceResearch article
The cause of urinary symptoms among Human T Lymphotropic 
Virus Type I (HLTV-I) infected patients: a cross sectional study
Paulo N Rocha*, Ana Paula Rehem, Juliana F Santana, Neviton Castro, 
Andre L Muniz, Katia Salgado, Heonir Rocha and Edgar M Carvalho
Address: Immunology Service, University Hospital Professor Edgard Santos, Federal University of Bahia, Rua Joao das Botas, s/n, 40110-160 
Salvador, BA, Brazil
Email: Paulo N Rocha* - paulonrocha@alumni.duke.edu; Ana Paula Rehem - ap_rehem@yahoo.com.br; 
Juliana F Santana - jufsan2000@yahoo.com.br; Neviton Castro - neviton_castro@uol.com.br; Andre L Muniz - muniz.a@terra.com.br; 
Katia Salgado - katia_salgado@yahoo.com.br; Edgar M Carvalho - imuno@ufba.br
* Corresponding author    
Abstract
Background: HTLV-I infected patients often complain of urinary symptomatology.
Epidemiological studies have suggested that these individuals have a higher prevalence and
incidence of urinary tract infection (UTI) than seronegative controls. However, the diagnosis of UTI
in these studies relied only on patient information and did not require confirmation by urine
culture. The purpose of this study was to investigate the role of urinary tract infection (UTI) as the
cause of urinary symptoms in HTLV-I infected patients.
Methods: In this cross sectional study we interviewed, and cultured urine from, 157 HTLV-I
seropositive individuals followed regularly at a specialized clinic. All patients were evaluated by a
neurologist and classified according to the Expanded Disability Status Scale (EDSS). Urodynamic
studies were performed at the discretion of the treating physician.
Results: Sixty-four patients complained of at least one active urinary symptom but UTI was
confirmed by a positive urine culture in only 12 of these patients (19%); the majority of
symptomatic patients (81%) had negative urine cultures. To investigate the mechanism behind the
urinary complaints in symptomatic individuals with negative urine cultures, we reviewed the results
of urodynamic studies performed in 21 of these patients. Most of them (90.5%) had abnormal
findings. The predominant abnormalities were detrusor sphincter hyperreflexia and dyssynergia,
findings consistent with HTLV-I-induced neurogenic bladder. On a multivariate logistic regression,
an abnormal EDSS score was the strongest predictor of urinary symptomatology (OR 9.87, 95% CI
3.465 to 28.116, P < 0.0001).
Conclusion: Urinary symptomatology suggestive of UTI is highly prevalent among HTLV-I
seropositive individuals but true UTI is responsible for the minority of cases. We posit that the
main cause of urinary symptoms in this population is neurogenic bladder. Our data imply that
HLTV-I infected patients with urinary symptomatology should not be empirically treated for UTI
but rather undergo urine culture; if a UTI is excluded, further investigation with urodynamic studies
should be considered.
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Human T Cell Lymphotropic Virus type I (HTLV-I) is a ret-
rovirus that infects T lymphocytes and may cause a wide
spectrum of clinical manifestations, including HTLV-I
associated myelopathy/tropical spastic paraparesis
(HAM/TSP), uveitis, and adult T cell leukemia. Fortu-
nately, the majority of seropositive individuals have no
signs or symptoms of illness attributable to HTLV-I infec-
tion [1]. However, a series of epidemiological studies have
suggested that HTLV-I-infected individuals are at
increased risk for urinary tract infections (UTI) [1-3].
The initial report of an association between HTLV-I serop-
ositivity and UTI was published in 1997 by the Retrovirus
Epidemiology Donor Study (REDS) group[1]. In this
report, asymptomatic adult blood donors recruited from
11 United States centers were asked at study entry if they
had been diagnosed with bladder or kidney infection
within the last 5 years. This cross-sectional data revealed a
higher prevalence of UTI among HTLV-I seropositive indi-
viduals compared to seronegative controls (24% versus
14.9%, P < 0.01). However, when adjusted for important
covariates in a multivariate model, the association
between HTLV-I seropositivity and UTI lost statistical sig-
nificance. In a subsequent study, the authors measured
the occurrence of UTI in the REDS cohort over a median
of two years [2]. HTLV-I-infected subjects were signifi-
cantly more likely to report bladder or kidney infection
than seronegative controls (17.6% versus 7.8%); in this
study, the association remained statistically significant
even after multivariable adjustment for relevant con-
founding variables (OR 2.79, 95% CI 1.63 to 4.79, P <
0.05). A more recent analysis of the same cohort with
longer follow-up arrived at similar findings [3].
It should be noted that in none of the above-mentioned
studies urine cultures were required to define UTI; the
investigators relied solely on patients' recollection of an
episode of UTI that was diagnosed and treated by a physi-
cian [1-3]. This may have led to a recall bias, as seroposi-
tive individuals are more likely to recall intercurrent
illnesses than healthy controls. Additionally, it is conceiv-
able that urinary symptoms related to neurogenic bladder
due to incipient HAM/TSP may have been misinterpreted
(and empirically treated) as infection, leading to an over
diagnosis of UTI in the seropositive group. To further
address the association between urinary symptoms and
UTI in this population, we prospectively interviewed and
performed urine culture on 157 HTLV-I-infected individ-
uals followed regularly at an ambulatory clinic located at




All patients were recruited from the HTLV-I ambulatory
clinic at Hospital Universitário Professor Edgard Santos
(HUPES), in Salvador, Bahia, which is the Brazilian city
with the highest prevalence of HTLV-I seropositivity in the
country [4]. This clinic is a referral center for local blood
banks and follows approximately 500 HTLV-I seropositive
patients. We recruited all consecutive patients presenting
to routine clinic visits between 01/08/2004 and 16/03/
2005. Sample size was determined by convenience. The
inclusion criteria were: age > 18 years, HTLV-I seropositiv-
ity confirmed by Western Blot, and willingness to partici-
pate and sign an informed consent form. All patients
underwent a thorough history and physical examination
performed by an experienced neurologist as well as labo-
ratory and image data, when deemed appropriate. The
patients were divided into three groups according to the
Expanded Disability Status Scale (EDSS) score [5]: 1) No
neurologic involvement, when the EDSS was zero; 2)
Incipient myelopathy; when 0.0 < EDSS < 3.0; and 3)
HAM/TSP, when EDSS ≥ 3.0. Additionally, the diagnosis
of HAM/TSP required a compatible clinical presentation,
presence of HTLV-I antibodies in the CSF; and exclusion
of alternative diseases that could be accounting for the
neurologic disability [6]. All participants agreed to partic-
ipate in the study and signed an informed consent form
prior to the interview and urine collection. The research
reported herein is in compliance with the Helsinki Decla-
ration and was approved by the ethics committee of
Fiocruz (number 029/2006).
Study design
This is a cross sectional study. On the same day, all
patients underwent a structured interview and provided a
urine sample for culture and sensitivities (C&S). Patients
were questioned about demographic data and presence of
urinary symptoms suggestive of UTI, such as dysuria,
urgency, frequency (defined as more than eight voids per
day) and supra pubic discomfort. Information on the
EDSS score was obtained from the patient's chart. The
results of urodynamic studies were also obtained by chart
review. This study did not have a protocol specified for
therapy of UTI or further investigation and treatment of
urinary symptoms. The clinical management of these
patients was left up to the discretion of the clinic physi-
cian, who had access to all of the studies performed.
Urine C&S
At the end of the clinic appointment, all patients provided
a urine sample for C&S. After genital hygiene with mild
soap, a mid-stream urine sample was collected on a sterile
container and immediately sent to the microbiology lab-
oratory. A calibrated loop (1/1000) was used to inoculate
McConkey and sheep blood agar plates, which were thenPage 2 of 7
(page number not for citation purposes)
BMC Infectious Diseases 2007, 7:15 http://www.biomedcentral.com/1471-2334/7/15incubated at 37°C and inspected 24 hours later for the
presence of bacterial growth. Plates that did not show any
evidence of bacterial growth were re-incubated for an
additional 24 hours. When bacterial growth was detected,
a gram stain was performed. Gram-negative bacteria were
identified using commercially available kits (Enterokits,
PROBAC). Gram-positive bacteria were identified with
the aid of biochemical studies and the coagulase test. For
antimicrobial susceptibility testing, bacteria were inocu-
lated onto Mueller-Hinton agar plates and incubated for
24 hours at 37°; sensitivities were determined by the disk
diffusion method, using zone diameter standards for anti-
biotic susceptibility obtained from the National Commit-
tee of Clinical Laboratory Standards [7]. All urine C&S
studies were performed at a single laboratory by the same
technician (KS). A positive urine culture was defined as
the growth of greater than 100.000 CFU/ml of a single
bacterial species [8]. Contamination was defined as the
growth of more than one species or the isolated growth of
Lactobacillus, alpha-hemolytic Streptococcus, Gard-
nerella or Corynebacteria [9].
Statistics
The data were summarized using mean ± standard devia-
tion (SD) or percentages (%). For the variable 'age', we
also split the population in intervals of two decades (start-
ing at age 18, since this was the entry criteria) to provide
further information about the age distribution of our
patients. The Mann-Whitney U test was used to compare
continuous variables (age) between two groups (HAM/
TSP versus others and symptomatic versus asympto-
matic). The Fisher's exact test was used to analyze the 2 ×
2 table of urinary symptoms and urine culture results.
Univariate and multivariate logistic regression analyses
were performed to identify predictors of urinary symp-
tomatology; the results of these analyses were reported as
odds ratios (OR) and 95% confidence intervals (CI). All
calculations were performed using SAS version 8.2 (Cary,
NC). P values < 0.05 were considered statistically signifi-
cant.
Results
We prospectively interviewed 157 patients presenting to a
routine clinic visit over a seven-month period. Mean (±
SD) age was 48 ± 12 years and 55% were female (Table 1).
The majority (52%) had no neurologic impairment, 27%
had incipient myelopathy and 21% had HAM/TSP. When
compared to the remainder of the population, HAM/TSP
patients were significantly older (53 ± 14 versus 47 ± 12
years, P = 0.027), with a slight (57.6%) male predomi-
nance (data not shown).
Upon direct questioning, 64 patients (41%) complained
of at least one active urinary symptom suggestive of UTI
(Table 1). Most of these patients (34/64 [53%]) reported
only one urinary symptom; two, three and four symptoms
Table 1: Characteristics of the population studied and urinary findings
Variable n = 157
Age (mean ± SD), years 48 ± 12
18 – 40 24% (37)
40 – 60 64% (101)
60 – 80 11% (17)
> 80 1% (2)
Gender
Male 45 % (71)







1.0 – 3.0 27% (42)
≥ 3.0 21% (33)
Urinary Symptoms





Mixed flora or < 100.000 CFU/ml 3% (5)
* Data available for 155 patients. Of the 33 patients with EDSS ≥ 3.0, most (n = 15) were in the 3.0 – 4.0.range. The remainders were distributed as 
follows: EDSS 4.0 – 6.0 = 6 patients; EDSS 6.0 – 8.0 = 8 patients; EDSS of 8.0 = 4 patients.Page 3 of 7
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most commonly reported symptom was supra-pubic dis-
comfort (33%), followed by urgency (26%), frequency
(25%) and dysuria (16%). There was no age difference
between symptomatic and asymptomatic patients but
most (71.9%) symptomatic patients were female (data
not shown).
Bacterial growth was detected in the urine of 21 patients.
In two cases, urine samples were judged contaminated
due to polymicrobial growth; in three others, bacterial
growth was less than 100.000 CFU/ml. Therefore, 16
patients (10%) were considered to have a positive urine
culture (Table 1). The organisms isolated in these 16 cul-
tures were: E. coli (09), K. pneumoniae (02), Staphylococcus
sp. (02), S. maltophilia (01), C. freundii (01) and P. mirabi-
lis (01). There was no statistically significant association
between age and urine culture results but the vast majority
of positive cultures (81.3%) occurred in women; only
three men had positive urine cultures, two of them with
HAM/TSP (EDSS scores of 3.0 and 8.0) and one with
incipient myelopathy (EDSS score = 1.0) (data not
shown).
Table 2 shows the correlation between urinary symptoms
and urine culture results. Among asymptomatic patients,
only four had significant bacteriuria; most asymptomatic
patients (89/93 [96%]) had a negative urine culture. Of
the 64 patients with urinary symptomatology, 12 patients
(19%) had actual UTI confirmed by a positive urine cul-
ture. There was a correlation between urinary symptoma-
tology and urine culture positivity as most positive
cultures came from symptomatic patients (P = 0.006,
Fisher's exact test). It should be noted, however, that uri-
nary complaints could not be explained by presence of
UTI in 81% of symptomatic patients. Fig. 1, shows the
prevalence of urinary symptoms and positive urine cul-
ture stratified by the degree of neurologic impairment as
determined by the EDSS score. Both prevalences increased
directly in relation to EDSS scores but in most patients,
the urinary complaints could not be explained by a posi-
tive culture.
To investigate the mechanism behind the urinary com-
plaints in symptomatic individuals with negative urine
cultures, we reviewed the results of urodynamic studies
performed in 21 of these patients. Most of them (90.5%)
had abnormal findings. The predominant abnormalities
encountered in these studies were detrusor sphincter
hyperreflexia (13/21 [61.9%]) and dyssynergia (4/21
[19%]); two patients (9.5%) were diagnosed with stress
incontinence and two (9.5%) had completely normal
urodynamic studies. Table 3 shows the urodynamic find-
ings distributed according to EDSS scores. Voiding dys-
function was not limited to patients with HAM/TSP as it
was found in all patients without neurologic involvement
and in five out of six patients with incipient myelopathy.
To examine the association between several covariates and
the presence of urinary symptoms, we performed univari-
ate and multivariate logistic regression analyses (Table 4).
On the univariate analysis, female gender, an abnormal
EDSS score, and a positive urine culture were significantly
associated with increased odds of urinary symptoms. On
the multivariate analysis, the only independent risk fac-
tors for urinary symptomatology were female gender and
an abnormal EDSS score, with the latter showing the most
significant association (OR 9.87, 95% CI 3.465 to 28.116,
P < 0.0001).
Discussion
In the current study, we have interviewed and performed
urine cultures on 157 consecutive HTLV-I-infected indi-
viduals presenting to a routine clinic visit to determine the
relation between active urinary symptomatology and the
presence of UTI. Several findings are noteworthy.
We encountered 64 patients complaining of at least one
urinary symptom; in 12 of these patients, the diagnosis of
UTI was subsequently confirmed by a positive urine cul-
ture. However, the vast majority (n = 52) of patients with
active urinary symptoms suggestive of UTI had negative
urine cultures. Upon further investigation of a subgroup
of these patients with urodynamic studies, we detected
findings suggestive of neurogenic bladder in 81% (17/21)
Table 2: Correlation between urinary symptoms and urine culture results
Urinary Symptoms
Urine Culture Absent Present Total (n)
Negative* 89 (96%) 52 (81%) 141
Positive 4 (4%) 12 (19%) 16
Total (n) 93 (100%) 64 (100%) 157
*We included five urine cultures that were either contaminated (n = 2) or had less than 100.00 CFU/ml (n = 3) among the Negative urine culture 
group.Page 4 of 7
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hyperreflexia and four cases of detrusor sphincter dyssyn-
ergia. These are the most frequently encountered types of
voiding dysfunction among patients with neurogenic
involvement of the bladder by HTLV-I [10-18]. In our
study, these abnormalities on urodynamic evaluation
were found even in patients with normal EDSS scores
(Table 3), perhaps suggesting that this scale might not
have adequate sensitivity to detect very early urologic
abnormalities in HTLV-I patients. It should be noted that
since the selection of patients for urodynamic evaluation
in this study was done on clinical grounds, it is possible
that the high incidence of neurogenic bladder encoun-
tered in these 21 patients represent a selection bias.
In a multivariate logistic regression analysis an abnormal
EDSS score was the strongest predictor of urinary symp-
tomatology: individuals with abnormal EDSS scores (=
1.0) had almost 10 times greater odds of having urinary
symptoms than individuals with EDSS scores of zero.
Nevertheless, we still found a significant prevalence of uri-
nary complaints (27.5%) among individuals with EDSS
scores of zero, adding to our reservation regarding the sen-
sitivity of this scale in this setting. Female gender was also
Prevalence of urinary symptoms and positive urine culture stratified by the degree of neurologic impairmentFigur  1
Prevalence of urinary symptoms and positive urine culture stratified by the degree of neurologic impairment. 
The gray bars represent the prevalence of urinary symptoms; the white bars, the prevalence of positive urine cultures; and the 
black bars, the percentage of urinary symptoms that may have been explained by a positive urine culture. Of the 80 patients 
without neurologic impairment (EDSS = 0.0), 22 (27.5%) had urinary symptoms and 05 (6.3%) had positive urine culture. Of the 
42 patients with incipient myelopathy (EDSS 1.0–3.0), 16 (38.1%) had urinary symptoms and 04 (9.5%) had positive urine cul-
ture. Of the 33 patients with HAM/TSP (EDSS = 3.0), 24 (72.7%) had urinary symptoms and 07 (21.2%) had positive urine cul-
ture. A positive urine culture may explain the urinary symptomatology in 23% (5/22), 25% (4/16), and 29% (7/24) of patients 








EDSS = 0.0EDSS 1.0|-3.0EDSS= or >3.0
Symptomatic Positive culture Culture may explain symptomsPage 5 of 7
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urine culture was associated with urinary symptomatol-
ogy on univariate analysis but lost statistical significance
on the multivariate model probably due to an interaction
with the variables gender and EDSS; this is because most
of the positive urine cultures occurred in females (13/16
[81%]) and in patients with abnormal EDSS (11/16
[69%]).
Murphy et al. have described an increased prevalence and
incidence of UTI among HTLV-I seropositive individuals
compared to a control group of seronegative blood
donors [1-3]. In their studies, however, the diagnosis of
UTI relied solely on patient's recollection, which may
have led to a recall bias in the HTLV-I seropositive group.
More importantly, even though patients were told to
report only episodes of UTI that were identified and
treated by a physician, this does not necessarily guarantee
an accurate diagnosis. Patients, especially young females,
are often treated empirically for UTI based on their symp-
toms, without confirmation by a urine culture [19]. There-
fore, it is plausible that in the studies by Murphy et al.,
HTLV-I-infected patients with urinary symptoms due to
neurogenic bladder may have been misdiagnosed as hav-
ing UTI.
There are limitations to our study. Since UTI is an acute
condition that resolves with treatment, we recognize that
measuring its punctual prevalence during pre-scheduled,
routine visits to an HTLV-I ambulatory clinic clearly
underestimates the burden of UTI in this population.
However, the main objective of our study was not to
detect the prevalence of UTI but rather the prevalence of
active urinary symptoms and identify what percentage of
these could be explained by UTI; therefore, we feel that
our study design and location were adequate to address
this issue. Another limitation is the lack of a seronegative
control group. Without the seronegative group, our results
cannot dispute the assertion of Murphy et al. that UTI is
more common in HTLV-I seropositive individuals. Never-
theless, the current study indicates that defining UTI in
this population based on data obtained from an interview
is inadequate and may lead to over diagnosis by detecting
a large proportion of patients with neurogenic bladder
that do not have infection.
Conclusion
Our study revealed a high prevalence of urinary symp-
toms among HTLV-I-infected individuals but most of
these patients did not have UTI. Urodynamic studies per-
formed in patients with active urinary symptomatology
and negative urine cultures revealed findings consistent
with neurogenic involvement of the bladder by HTLV-I.
Additionally, an abnormal EDSS score was a strong pre-
dictor of urinary symptomatology. We conclude that neu-
rogenic bladder might be an early sign of HAM/TSP and
the most likely cause of urinary symptomatology in
HTLV-I-infected individuals presenting to a routine clinic
Table 3: Urodynamic Findings Distributed According to EDSS Scores in 21 Patients with Urinary Symptomatology and Negative Urine 
Cultures
EDSS Score
Urodynamic Findings 0.0 1.0 – 3.0 ≥ 3.0 Total (n)
Normal 0 1 1 2
*DS Hyperreflexia 5 3 5 13
*DS Dyssynergia 0 1 3 4
Stress Incontinence 0 1 1 2
Total (n) 5 6 10 21
*DS – detrusor sphincter
Table 4: Predictors of urinary symptomatology in HTLV-I-infected individuals
Univariate Logistic Regression Multivariate Logistic Regression
Variables OR 95% CI P value OR 95% CI P value
Age 1.01 0.98 to 1.03 0.5975 1.00 0.97 to 1.03 0.7535
Gender (fem. vs. male) 3.39 1.71 to 6.70 0.0003 5.05 2.13 to 11.96 0.0002
EDSS (≥ 1.0 vs. 0.0) 5.89 2.50 to 13.88 < 0.0001 9.87 3.47 to 28.12 < 0.0001
Urine culture (pos. vs. neg.) 5.14 1.57 to 16.75 0.0033 2.870 0.78 to 10.61 0.1141
Footnote: N = 155 (2 missing data for EDSS). Age was used as a continuous variable; fem. = female; pos. = positive; neg. = negative; OR = odds 
ratio; CI = confidence intervals.Page 6 of 7
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visit. Our data implies that HLTV-I infected patients with
urinary symptomatology should not be empirically
treated for UTI but rather undergo urine culture; if a UTI
is excluded, further investigation with urodynamic studies
should be considered.
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